GoldStone Investment Co.,Ltd. is a private equity general partner firm headquartered in Beijing, China.
Gold Stone Investment participated in a $65m round of funding for CanSino Biologics, a China-based vaccine developer.
CITIC Capital, Goldstone Investment and others have completed their $1.9bn acquisition of US-listed chipmaker OmniVision Technologies.
Goldstone Investment and Legend Capital have led a $280m round of financing for Pharmaron, a Chinese contract research organization company.
Read more news concerning GoldStone Investment Co.,Ltd.
A sampling of GoldStone Investment Co.,Ltd. portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?